Skip to the page

Data / Federal grants / RFA-MH-27-125

Mechanistic Evaluation of Therapeutic Targets derived from Treatable Traits to Improve CNS Outcomes in People with HIV (R21/R33 Clinical Trial Not Allowed)

National Institutes of Health (Department of Health and Human Services) is accepting applications until October 28, 2027.

SpecStream is the live web data engine for teams and agents. It reads every open and forecast federal opportunity on Grants.gov each morning, and this page is that reading. Describe your organization once and the grants that fit arrive in your sheet, CRM, Slack or agent as they are posted.

Key facts

Opportunity number
RFA-MH-27-125
Status
Posted, open
Posted
September 30, 2026
Closes
October 28, 2027
Cost sharing
Not required
Funding instrument
Grant
Category
Health
Assistance listing
93.242 Mental Health Research Grants; 93.279 Drug Use and Addiction Research Programs; 93.853 Extramural Research Programs in the Neurosciences and Neurological Disorders
Contact
National Institutes of Health · [email protected] · 301-402-2541

Who can apply

  • For profit organizations other than small businesses
  • Others (see text field entitled "Additional Information on Eligibility" for clarification)
  • Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
  • Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
  • Public and State controlled institutions of higher education
  • Public housing authorities/Indian housing authorities
  • Private institutions of higher education
  • County governments
  • Small businesses
  • State governments
  • Native American tribal organizations (other than Federally recognized tribal governments)
  • Native American tribal governments (Federally recognized)
  • Special district governments
  • City or township governments
  • Independent school districts

Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility.Foreign Organizations/International CollaborationsNon-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.

What the agency says

The purpose of this notice of funding opportunity (NOFO) is to identify modifiable mechanisms and therapeutic targets to address central nervous system (CNS) complications associated with human immunodeficiency virus (HIV). The initiative supports a phased research approach beginning with the identification of patient phenotypes characterized by convergent pathophysiological features, followed by the discovery and experimental validation of molecular mechanisms using innovative in-vitro and in-vivo models. The goal of this NOFO is to advance therapeutic target, and intervention discovery to address the multifactorial and heterogeneous nature of HIV-associated CNS dysfunction.

The notice on Grants.gov

Other open grants from the Department of Health and Human Services

All grants open to For profit organizations other than small businesses · All grants open to Nonprofits (501(c)(3)) · All grants open to Nonprofits without 501(c)(3) status · Everything closing in October 2027

Read from the Grants.gov API, last updated 2026-10-23. The agency's notice on Grants.gov is the official record; check it before you apply.